On August 26, UNM Rainforest Innovations (formerly STC.UNM) will host a virtual Innovation Showcase to feature the latest developments in research and technology from the University of New Mexico. Six researchers will present on both life-science and physical-science technologies. This virtual event will bring together entrepreneurs, investors, and industry representatives to learn more about commercialization opportunities. UNM Rainforest Innovations is the technology-transfer and economic-development organization for the University of New Mexico …Read More
UNM Startup GPER G-1 Development Group Receives STTR Grant
The National Institutes of Health (NIH) via the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $300,000 grant to GPER G-1 Development Group to support their project, “Development of an innovative diabetes therapeutic via GPER targeting.” GPER G-1 Development Group is a drug discovery and development company with the primary goal of advancing novel drug candidates that target GPER. The company has licensed a collection …Read More
UNM Startup Avisa Pharma to go Public on Toronto Exchange
Local startup company Avisa Pharma, Inc. has announced that this summer it is planning to go public on the TSX Venture Exchange in Toronto. Avisa Pharma, Inc. was formed to commercialize Dr. Graham Timmins’ breath-test technology for early detection and treatment of lung infections. The company developed a rapid, 10-minute, point-of-care biomarker breath test for the detection and monitoring of bacterial pneumonia and other pulmonary infections. This would allow doctors …Read More
BennuBio Inc. Secures $5M Investment
UNM Start-up BennuBio, Inc. has successfully closed on a $5 Million investment. See more in Kevin Robinson-Avila’s March 27, 2020 article, “Local tech startup snares $5M investment,” from the Albuquerque Journal, reprinted below. Local tech startup snares $5M investment By Kevin Robinson-Avila / Journal Staff Writer Published: Friday, March 27th, 2020 at 1:24pm Updated: Friday, March 27th, 2020 at 11:26pm Copyright © 2020 Albuquerque Journal BennuBio Inc. has won $5 million in private …Read More
GPER G-1 DEVELOPMENT GROUP ANNOUNCES: RESEARCHERS AT THE UNIVERSITY OF NEW MEXICO PUBLISH THEIR ADVANCEMENTS IN TREATING DIABETES AND OBESITY IN RENOWNED MEDICAL JOURNAL
Eric Prossnitz, Distinguished Professor of Internal Medicine; Chief, Division of Molecular Medicine at the University of New Mexico Health & Sciences Center, has discovered a novel therapeutic for the treatment of diabetes and obesity. FEBRUARY 20, 2020 FOR ADDITIONAL INFORMATION: JOHN CHAVEZ, (505) 660-1046 Albuquerque, NM, FEBRUARY 20TH, 2020 – GPER G-1 Development Group, a portfolio company of the New Mexico Start-up Factory, is a New Mexico-based drug discovery company …Read More
Local Startup on the Cutting Edge of Developing Long-Lasting, High Performance Materials for Solar Panels
Local startup Osazda Energy is commercializing solar cell technology jointly developed at the University of New Mexico and the Air Force Research Laboratory-New Mexico by UNM Regents’ Professor Sang M. Han and his team, and AFRL Senior Physicist David Wilt. Osazda, a New Mexico Angels Start-Up Factory II-funded company, is developing innovative new materials that improve the efficiency and life of solar cells and panels for the photovoltaic market. Solar …Read More
UNM/UPenn Technology Receives FDA IND Clearance
A drug discovered more than a decade ago at UNM and NMSU by Dr. Eric Prossnitz (UNM) and Dr. Jeffrey Arterburn (NMSU) and combined with a drug discovered at the University of Pennsylvania in 2017 has received FDA clearance as an Investigational New Drug (IND). The new drug will now advance to human clinical trials for patients with advanced cancers. The co-inventors on the team effort that discovered the compound …Read More
AgilVax Chairman Assumes CEO Role
New Mexico biotech company Agilvax, Inc., headquartered in Albuquerque, with offices in El Paso and at the Johnson & Johnson Innovation labs at Texas Medical Center (JLABS @ TMC) in Houston, announced that Joseph Patti has been appointed President & CEO. Patti, the company’s former chairman replaces Dr. Federica Pericle, who stepped down as CEO in June. AgilVax is commercializing a virus-like particle (VLP) technology platform, developed by researchers Dr. …Read More
NM Company Launching Breakthrough Beauty Product Using UNM Technology
New serum expected to significantly impact beauty industry Albuquerque, NM – August 7, 2019. People will go to great lengths, including invasive medical procedures, to reduce the appearance of wrinkles, acne scars and stretch marks. But the need for this may well be a thing of the past, thanks to K&K Biotech’s new serum. The soon-to-be-released product includes a new, patented molecule that was created at The University of New …Read More
New Mexico Company Moving Medical Device Closer to Clinical Trials and Market
New Mexico startup Avisa Pharma, formed to commercialize breath-test technology created at The University of New Mexico, is moving closer to bringing its innovative medical device to market. The technology was developed by UNM Associate Professor Graham Timmins from the Department of Pharmaceutical Sciences at the College of Pharmacy for the early detection and treatment of lung infections. Avisa, a clinical-stage company, licenses the technology from STC and has developed …Read More